Age-Related Macular Degeneration (AMD) · Alzheimer's · Back and Neck Problems · Cardiovascular Diseases · cardiovascular Health · COPD · Dementia · Diabetes Mellitus · Dry Eyes · Hypertension · Kidney Health · NMN · Osteoporosis ·

Senior Wellness Made Simple: The Senior's Guide to a Vibrant Life

Senior Health

Table of Contents

Overview

The global population is aging rapidly, with significant demographic shifts forecasted. By 2030, 1 in 6 people worldwide will be over 60, increasing from 1 billion in 2020 to 1.4 billion, and by 2050, the number will double to 2.1 billion. Aging is accelerating in low- and middle-income nations, with two-thirds of older individuals expected to reside in these countries by 2050.

Aging biologically involves cumulative molecular and cellular damage, leading to reduced physical and mental capacities, and increased disease risk. Factors like retirement, relocation, and loss of loved ones also significantly influence aging experiences.

Common health conditions in aging include back and neck pain, osteoporosis, and chronic diseases like COPD, diabetes, and dementia. With advancing age, the likelihood of experiencing multiple conditions simultaneously increases. Older age also brings complex health states known as geriatric syndromes, including frailty, urinary incontinence, falls, and delirium, emphasizing the importance of understanding these conditions for improving elderly health and quality of life.

Let's explore the most prevalent age-related diseases and their impacts on health and quality of life in the elderly. [1,2,3,4]

Hypertension

About 60% of seniors are treated for hypertension, a common condition where the heart pumps blood against narrow, resistant arteries, leading to high blood pressure. Often undetected, it can cause serious issues like strokes and heart attacks. To prevent or manage hypertension:

  • Maintain a healthy weight; losing 10 pounds can lower blood pressure.
  • Reduce stress.
  • Limit salt and alcohol.
  • Exercise regularly with aerobic, stretching, and muscle-strengthening activities.
  • Monitor your blood pressure regularly to catch pre-hypertension early.

Proactive management of these factors is crucial for healthy blood pressure and well-being in older adults.

For more information, check our full hypertension guide. [5]

Diabetes

Approximately 27% of older adults are treated for diabetes, a condition caused by insulin resistance or deficiency, essential for converting food into energy. Poor insulin function can elevate blood sugar levels, increasing the risk of complications like kidney and heart diseases or blindness, especially after age 45. To prevent or manage diabetes:

  • Eat a balanced diet, monitor carbs and calories, and discuss alcohol with your healthcare provider.
  • Exercise for 30 minutes, five times a week, to control blood glucose and weight.
  • If pre-diabetic, aim to lose 5-7% body weight.

For detailed information, refer to our comprehensive diabetes guide. [6]

Cardiovascular Diseases

As people get older, heart-related diseases become more common. These include high blood pressure, heart failure, heart attacks, and strokes. Nearly half of people in their 40s and 50s have these issues, and this goes up to about 85% for those over 80.

Heart diseases are a major cause of death for people over 65. As we age, our heart and blood vessels change, leading to problems like a thicker heart wall and stiffer heart valves. This can make the heart work less efficiently.

For a comprehensive understanding of cardiovascular health, explore our full guide on cardiovascular health. [7]

Osteoporosis

Osteoporosis

Osteoporosis, marked by brittle bones, mainly impacts the elderly, particularly postmenopausal women, often due to hormonal shifts or low calcium or vitamin D.

Its precursor, osteopenia, represents decreased bone density but is less severe than osteoporosis. Early detection and management of osteopenia are crucial for preventing its progression to osteoporosis, particularly in individuals with a high fracture risk. [8]

Osteoporosis Risk Factors

Osteoporosis varies in risk between men and women:

  • Women: Higher risk post-menopause due to decreased estrogen, crucial for bone health. Key factors include early menopause (before 45), hysterectomy with ovary removal, and prolonged amenorrhea due to extreme exercise or dieting.
  • Men: Often linked to lowered testosterone levels, necessary for bone upkeep. Causes include medication use (like steroids), alcohol abuse, and hypogonadism.
  • General Risk Factors: Includes hormonal imbalances (overactive thyroid, hyperparathyroidism, pituitary disorders), family history, low BMI, long-term steroid use, eating disorders, excessive alcohol and smoking, rheumatoid arthritis, malabsorption issues, certain cancer medications, and prolonged inactivity.

These factors collectively influence the development and increased risk of osteoporosis. [9,10]

Diagnosing Osteoporosis and Osteopenia

Diagnosing Osteoporosis and Osteopenia involves a Bone Mineral Density Test (DEXA Scan), the primary method for measuring bone density. This quick, comfortable test, taking about 10-20 minutes, compares your bone density with that of a healthy young adult. Results are presented as a T score:

  • T score above -1 SD: Normal bone density.
  • T score between -1 and -2.5 SD: Osteopenia (decreased bone density).
  • T score below -2.5 SD: Osteoporosis (significant bone loss).

Understanding these scores is crucial for early treatment and maintaining bone health. [11]

Management of Osteoporosis: Treatment and Fracture Prevention

Osteoporosis management targets fracture prevention and bone strengthening, tailored to individual factors like age, gender, and fracture risk. Treatment, guided by bone density scans, may not always require medication but emphasizes the importance of sufficient calcium and vitamin D, obtainable through diet or supplements.

Medications for Osteoporosis

Osteoporosis treatment includes various medications such as:

  • Bisphosphonates: Includes alendronic acid, and risedronate. Reduces fracture risk by slowing bone breakdown. Taken on an empty stomach. Possible side effects: stomach pain, rare risk of osteonecrosis of the jaw.
  • Selective Estrogen Receptor Modulators (SERMs): Example - raloxifene. Helps maintain bone density in postmenopausal women. Potential increased risk of blood clots.
  • Parathyroid Hormone Treatments: Used in severe osteoporosis to stimulate new bone growth. Side effects can include nausea and headaches.
  • Biological Medicines: Such as denosumab, an alternative for severe cases. Side effects may include muscle pain and constipation.
  • Calcium and Vitamin D Supplements: Essential for bone health. Typical daily need: 700 mg of calcium and 10 micrograms of Vitamin D.
  • Hormone Replacement Therapy (HRT): Used for early menopause; helps strengthen bones and manage symptoms. Slight risks include breast cancer and blood clots; consultation with a GP is advised.

Choosing the right medication for osteoporosis should be based on individual health needs and a doctor's advice, considering potential benefits and risks. [12,13,14]

Healing from a Bone Fracture

Osteoporosis doesn't affect the natural bone healing process. Fractures, depending on their severity, may heal with or without surgical intervention. Typically, recovery takes 6 to 12 weeks, though this varies. To aid healing:

  • Eat a nutritious, protein-rich diet.
  • Avoid smoking to ensure better blood flow to the bones.
  • Rest adequately for gradual recovery.

Fracture pain usually decreases over time. Different fractures have unique healing timelines and may need specific care:

  • Broken Wrist: Heals in about 6 to 12 weeks.
  • Spinal Fracture: Involves compression of spine bones.
  • Broken Hip: Often requires surgery for repair.

Each fracture type demands its rehabilitation approach. [15,16,17,18]

Osteoporosis Prevention

Maintaining bone health involves:

  • Exercise Regularly: Aim for 150 minutes of weekly exercise, including weight-bearing and resistance activities. If you have osteoporosis, consult a healthcare professional before starting new exercises.
  • Balanced Diet: Ensure your diet includes 700mg of calcium and 10 micrograms of vitamin D daily.
  • Lifestyle Modifications: Quit smoking, moderate alcohol intake, and remove tripping hazards at home.
  • Regular Health Check-Ups: Have frequent eye and ear exams, and use hip protectors to reduce fall risks.
  • Pain Management: Employ methods like medication, heat or cold treatments, relaxation techniques, and massage therapy.
  • Workplace Adjustments: Discuss with your employer or GP about making changes to reduce fall or fracture risks at work.

Remember, it's important to seek support and advice for managing osteoporosis to ensure proper care and overall well-being. [19,20,21]

NMN, Resveratrol, and Quercetin's Role in Enhancing Bone Strength and Repair

Nicotinamide Mononucleotide (NMN) shows potential in improving bone health, particularly in osteoporosis and related bone diseases.

Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin show potential in improving bone health, particularly in osteoporosis and related bone diseases.

NMN enhances bone repair by boosting bone marrow cell function and rejuvenates aging bone cells, potentially benefiting osteoporosis. Resveratrol, known for its anti-inflammatory and antioxidant properties, helps in maintaining bone density and reducing bone loss by promoting osteoblast activity and inhibiting osteoclast formation. Quercetin, a flavonoid, also contributes to bone health by reducing oxidative stress and inflammation, which are key factors in bone degeneration. These supplements also maintain bone density in microgravity conditions, like those faced by astronauts, and may counteract bone weakness from prolonged medication use. Additionally, they offer protection against bone damage due to excessive aluminum exposure. Further studies are needed to confirm their effectiveness in human bone health.

For more details, explore our comprehensive guide to understand their implications for bone wellness. [22,23,24,25,26,27]

Back and Neck Problems

Back and Neck Problems

Back or neck discomfort, akin to graying hair or misplaced keys, often accompanies aging. But it's essential to discern normal pain from signs of a more serious issue. Many wonder about the severity of their back pain and whether it's a typical aging sign or indicative of a larger health concern.

Is It Expected?

Back or neck pain is common with age, typically beginning between ages 40 to 60. While some discomfort is normal, symptoms like severe pain, fevers, unexplained weight loss, increased night-time pain, bladder issues, leg pain, numbness, or persistent pain after rest should prompt a doctor’s visit.

Pain during regular tasks or after an injury also requires medical attention. Untreated, these symptoms can worsen. Treatments range from medications and therapy to surgery. Prevention includes regular exercise and maintaining good posture. [28]

Back or Neck Pain Causes

Back or neck pain is a common ailment that can arise from various spinal conditions. These include:

  • Herniated Discs: A common cause of back pain, especially in younger adults, where disc material leaks and irritates nerves.
  • Aging Discs: In older adults, discs become less flexible, increasing the likelihood of herniation and pain.
  • Cervical Spondylosis: Often leads to neck pain, involving wear and tear on neck bones and cartilage, resulting in discomfort and stiffness.
  • Spinal Stenosis: Characterized by the narrowing of the spinal canal, causing pain, numbness, or muscle cramping. Aging is a major risk factor, but it can also result from herniated discs, bone diseases, tumors, or spinal injuries.

Understanding the underlying causes of back and neck pain is crucial for effective diagnosis and treatment. These conditions vary in their severity and impact on daily activities, highlighting the importance of medical consultation for proper management. [29, 30,31,32]

Preventing and Managing Back & Neck Pain in the Elderly

Effective strategies can prevent or manage back and neck pain in the elderly. Key approaches include:

  • Maintain a Healthy Weight: Reduces strain on the spine and musculoskeletal system.
  • Consult a Physician Before Exercise: Essential to ensure the safety and suitability of exercises.
  • Engage in Low-Impact Exercises: Activities like walking, cycling, swimming, and yoga help in weight management and strengthen back and abdominal muscles.
  • Incorporate Gentle Stretching: Enhances posture and flexibility, reducing the risk of pain.
  • Adjust Lifestyle for Better Posture: Setting computer screens at eye level and being mindful of sleeping positions.
  • Quit Smoking: Smoking is linked to increased risk of back and neck pain and other health complications.

Adopting these strategies can help seniors effectively manage and reduce back and neck pain, enhancing their overall quality of life. [33,34,35,36,37]

Consultation and Risks for Back & Neck Pain

Seek medical attention for back and neck pain that persists, is severe, or follows an injury, especially in the elderly. Key symptoms warranting a doctor's visit include:

  • Pain spreading to arms or legs
  • Night-time worsening
  • Numbness or tingling
  • Muscle weakness
  • Fever, headaches
  • Loss of bladder/bowel control
  • Unexplained weight loss

Delaying medical care can lead to serious complications, such as permanent nerve damage and chronic pain, which can disrupt sleep and mental well-being. Timely treatment is crucial for maintaining quality of life and preventing further deterioration. [38,39]

Musculoskeletal Disorders and Supplements

Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin are emerging as promising supplements for musculoskeletal disorders related to aging, injury, or autoimmune conditions.

Research suggests NMN's effectiveness in enhancing muscle strength, particularly in age-related decline and diseases like ALS. Key findings include improved muscle performance in the elderly, potential benefits for ALS muscle issues, and increased endurance in athletes. Resveratrol has shown benefits in improving muscle function and reducing muscle atrophy through its antioxidant properties. Quercetin, with its anti-inflammatory effects, helps in muscle recovery and reducing muscle damage after strenuous activities. The combined role of these supplements in rejuvenating aging muscles and mitochondria in ALS models highlights their potential in diverse musculoskeletal health scenarios.

For more details, refer to NMN, Resveratrol, and Quercetin articles. [40,41,42,43,44]

Age-Related Macular Degeneration (AMD)

Age-related macular degeneration (AMD) is a common eye condition in older adults, affecting the macula in the retina, which is essential for clear central vision. While it doesn't cause total blindness, it impairs activities like reading, driving, and recognizing faces.

AMD can be slow or rapid in progression and doesn't always impact vision immediately, making regular eye exams important for early detection. It's prevalent, with about 11 million cases in the U.S. alone, and having late-stage AMD in one eye increases the risk in the other eye. [45]

What Are the Types and Stages of AMD?

AMD comes in two forms: dry and wet.

  • Dry AMD: The more common type, characterized by the thinning of the macula as part of the aging process. It progresses slowly through three stages: early, intermediate, and late. In late-stage dry AMD, there's no cure, but strategies exist to maximize remaining vision. Preventative measures are important for the unaffected eye when only one is involved.
  • Wet AMD: Less common but more serious, often leading to rapid vision loss. Dry AMD can progress to wet AMD, which is always considered late-stage. It occurs due to abnormal blood vessel growth damaging the macula. Treatment options are available for wet AMD.

Regular eye exams are crucial for early detection and management of AMD. [46,47]

AMD Symptoms

AMD symptoms intensify as the condition progresses. Early detection is key:

  • Early Stage: In this phase, individuals typically do not experience any noticeable symptoms.
  • Intermediate Stage: This stage is characterized by mild vision blurriness and increased difficulty seeing in dim lighting conditions.
  • Late Stage (Wet or Dry): At this advanced stage, symptoms can include wavy or distorted lines, blurry central vision, the appearance of blank spots in the field of vision, faded colors, and poor vision in low-light environments.
  • Critical Indicator: The presence of wavy lines is a critical indicator and signals the need for an immediate consultation with an eye doctor.

Prompt medical attention is crucial if you notice any late-stage symptoms. Timely intervention can significantly affect AMD management. [48]

AMD Risk Factors

Age is a primary factor in developing Age-Related Macular Degeneration (AMD), particularly after 55. Other significant risk factors include:

  • Family history of AMD
  • Being Caucasian
  • Smoking

Regular eye exams are vital for those at risk, even in the absence of symptoms. Early stages of AMD often show no signs, so it's important to get checked regularly as recommended by your doctor. [49]

Tips to Reduce the Risk of AMD

To reduce your risk of AMD or slow down its progression, consider these lifestyle changes:

  • Stop smoking, or better yet, never start.
  • Exercise regularly.
  • Keep your blood pressure and cholesterol in check.
  • Eat a balanced diet, including green leafy veggies and fish.

Making these changes can significantly impact your eye health and overall well-being. [50]

AMD Eye Test and Diagnosis

Testing for AMD involves a routine eye examination with pupil dilation, where the doctor uses eye drops to widen the pupil for a better view inside the eye, assessing for AMD and other conditions.

Additionally, a specialized test known as optical coherence tomography (OCT) may be used to capture detailed images of the eye's interior. [51]

What Are the Treatments for AMD?

Treatment Options for AMD by Stage and Type:

  • Early AMD: For early Age-related Macular Degeneration (AMD), there is no specific treatment required. It is important to have regular eye monitoring and maintain a healthy lifestyle, which includes a balanced diet, regular exercise, and avoiding smoking.
  • Intermediate AMD: In cases of intermediate AMD, the use of vitamins and minerals is often recommended to help prevent the progression to late-stage AMD. Additionally, supplements may be beneficial in slowing down the condition in the other eye if one eye has already progressed to late AMD.
  • Wet AMD: Treatment for Wet AMD typically involves anti-VEGF (Vascular Endothelial Growth Factor) medication injections directly into the eye. Another treatment option is Photodynamic Therapy (PDT), which combines drug injections with laser treatment.
  • Advanced Dry AMD: Currently, there is no available treatment for Advanced Dry AMD. However, ongoing research efforts are focused on finding effective treatments. Support is available for individuals to manage vision loss associated with this condition.
  • Coping with Vision Loss from AMD: It is important to note that not all cases of AMD result in severe vision loss or affect both eyes. Low vision, where regular methods such as glasses or surgery cannot fully restore vision, can be managed with various tools and vision rehabilitation services. Vision rehabilitation aims to help individuals adapt to low vision, maintaining their independence and activity levels.

It's important to discuss these treatment options with your healthcare provider to determine the best approach for your individual case of AMD. [52,53]

The Promise of NMN, Resveratrol, and Quercetin in Age-Related Macular Degeneration

While existing AMD treatments have limitations, recent studies highlight Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin as promising options, particularly for the prevalent 'dry' form of AMD.

A 2020 study in Redox Biology demonstrated NMN's potential in enhancing mitochondrial function in retinal cells, offering hope for improved treatment outcomes in AMD. Resveratrol's antioxidant properties protect retinal cells from oxidative damage, while Quercetin's anti-inflammatory effects reduce retinal inflammation and support overall eye health. These supplements collectively offer a comprehensive approach to managing and potentially improving AMD symptoms.

For detailed insights, refer to our comprehensive guide. [54]

Dry Eyes

Dry Eyes

Dry eye disease occurs when your eyes aren't adequately lubricated, either due to insufficient tear production or poor tear quality. This can lead to eye discomfort, often experienced as stinging or burning, particularly in environments like airplanes, air-conditioned rooms, or after prolonged screen use. Managing dry eyes typically involves lifestyle adjustments and the use of eye drops to alleviate symptoms.

Risk Factors for Dry Eyes

These factors increase the likelihood of experiencing dry eyes:

  • Age: Dry eyes are more common in people over 50 due to decreased tear production.
  • Gender: Women, especially during hormonal changes like pregnancy, menopause, or when using birth control pills, are at higher risk.
  • Diet: A diet low in vitamin A (e.g., liver, carrots, broccoli) and omega-3 fatty acids (e.g., fish, walnuts, vegetable oils) can lead to dry eyes.
  • Eye Strain: Risk increases for contact lens wearers and those who have had refractive eye surgery.

These factors combined—age, gender, diet, and eye strain—significantly raise the likelihood of developing dry eyes. [55]

Dry Eyes Symptoms

Common signs of eye discomfort typically affecting both eyes include:

  • Stinging, burning, or scratchy sensations
  • Stringy mucus
  • Sensitivity to light
  • Redness
  • Feeling of a foreign object in the eyes
  • Difficulty with contact lenses
  • Night driving challenges
  • Excessive tearing as a response to dryness
  • Blurred vision or eye fatigue

Consult an eye care professional if you encounter any of these symptoms for appropriate diagnosis and treatment. [56,57]

Causes of Dry Eyes

Dry eyes arise from issues in the tear film, essential for eye moisture. This condition can result from a variety of factors:

  • Common Causes: Hormonal changes, autoimmune diseases, eyelid gland inflammation, and allergies can affect tear production or quality.
  • Tear Production and Drainage: Tears, produced by the lacrimal glands, spread over the eye when blinking. Insufficient production leads to dry eyes.
  • Reduced Tear Production: Age, diseases like Sjogren's syndrome, certain medications, and effects from contact lenses or laser surgery can decrease tear production.
  • Increased Tear Evaporation: Blocked oil glands in eyelids, infrequent blinking, eyelid problems, eye allergies, preservative eye drops, and environmental factors like wind or dry air can hasten tear evaporation.

Overall, dry eyes may result from reduced tear production or increased evaporation, influenced by health conditions, environmental elements, and specific treatments. [58]

Complications from Dry Eyes

Dry eyes can lead to several issues, including:

  • Increased risk of eye infections due to reduced tear production.
  • Potential eye damage, such as inflammation, corneal scratches, or sores, possibly leading to vision loss.
  • Difficulty in everyday activities like reading.

These risks underline the need for timely treatment of dry eyes. [59]

Dry Eyes Prevention

Minimize dry eyes with these tips:

  • Avoid Direct Air: Keep air from fans, air conditioners, and hair dryers away from your eyes.
  • Humidify: Use a humidifier in dry indoor environments.
  • Protect Your Eyes: Wear sunglasses or add safety shields to glasses.
  • Rest Your Eyes: Blink frequently and take breaks during prolonged reading or screen time.
  • Adjust Screen Position: Place computer screens below eye level to lessen eye strain.
  • Avoid Smoke: Stay clear of smoking and secondhand smoke.
  • Use Eye Drops: Regularly apply artificial tears to keep eyes lubricated.

Consult your healthcare provider for personalized advice. [60]

NMN, Resveratrol, and Quercetin's Role in Dry Eye Disease Treatment

Dry Eye Disease (DED) significantly impacts life quality, necessitating more effective treatments. Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin emerge as promising solutions.

A 2021 study highlighted NMN's ability to protect eye cells in DED-like conditions, primarily through enhancing NAD+ levels and activating SIRT1, reducing inflammation and aiding cell healing. Resveratrol supports tear production and reduces oxidative stress in the eyes, while Quercetin's anti-inflammatory properties help in managing eye dryness and discomfort. While promising, further research is needed to confirm their effectiveness in human DED treatment.

For more details, explore NMN, Resveratrol, and Quercetin articles. [61]

Age-Related Kidney Diseases

Kidney and urinary tract issues become more prevalent with age and can increase the risk of cardiovascular diseases. Early detection and management of kidney diseases are vital to preserve kidney function. Often, kidney disease may not exhibit obvious symptoms. Those at risk should have regular kidney health assessments, including blood and urine tests and blood pressure checks, at least once every two years.

Kidney Diseases Linked to Aging

As we age, the risk of kidney and urinary tract diseases increases. Key conditions affecting older adults include:

  • Kidney Inflammation: Conditions like glomerulonephritis can cause kidney swelling.
  • Diabetes: A major cause of kidney disease, potentially damaging kidneys even with good management.
  • Urinary Tract Infections (UTIs): Common in seniors, especially women, and can escalate into kidney infections.
  • Urinary Incontinence: Often leads to UTIs and may signify severe kidney issues or other health problems.
  • Renovascular Disease: Involves narrowing of renal arteries due to substances like cholesterol, affecting blood pressure and kidney function.
  • High Blood Pressure: Uncontrolled, it can lead to kidney damage, heart attacks, and strokes.
  • Hereditary Kidney Diseases: Such as polycystic kidney disease, which is genetically inherited.
  • Kidney Scarring: Typically originating in childhood due to urinary reflux.

Regular medical check-ups are crucial for early detection and management of these conditions to maintain kidney health in older adults. [62]

Symptoms of Age-Related Kidney Diseases

Age-related kidney diseases often progress silently, with symptoms becoming noticeable only as the disease advances. These symptoms can be general or specific and include:

  • General Symptoms: Elevated blood pressure, changes in urination frequency and appearance, swelling in legs and ankles, fatigue, and decreased appetite.
  • Specific Symptoms: Presence of blood in urine (hematuria), proteinuria (elevated protein levels in urine), increased serum creatinine, electrolyte imbalances, and hard-to-control hypertension.
  • Other Indicators: Pain near the kidneys, trouble sleeping, cognitive challenges, itching, respiratory difficulty, gastrointestinal issues, and a metallic taste in the mouth.
  • Cardiovascular Risks: Chronic kidney disease, especially in advanced stages, significantly increases the risk of cardiovascular problems, including a two to threefold higher risk of heart attacks. It's the leading cause of death among patients on dialysis or with kidney transplants.

These symptoms, particularly in older adults, may indicate underlying conditions like glomerulonephritis or nephrotic syndrome. Early detection and regular monitoring of kidney health are crucial in managing these risks and preventing further damage, particularly to heart health. [63,64,65,66,67,68]

Risk Factors for Kidney Disease in the Elderly

The risk of kidney disease in older adults increases due to several factors. Key risk factors include:

  • Being 60 years or older.
  • Diabetes 
  • Overweight or obesity.
  • High blood pressure.
  • History of heart issues (heart failure, past heart attacks) or stroke.
  • Smoking
  • Family history of kidney failure.
  • Past acute kidney injury.
  • Belonging to Aboriginal or Torres Strait Islander communities (for those over 18). 

A healthy lifestyle and regular medical check-ups are essential in reducing these risks. [69,70]

Maintaining Kidney Health in Aging

Preserving kidney function as you age involves several key steps:

  • Diabetes Management: For those with diabetes, strict blood sugar control is vital. Follow your doctor's advice on insulin, medications, diet, exercise, and blood sugar testing.
  • Blood Pressure Control: Regularly monitor your blood pressure. Medications such as ACE inhibitors or angiotensin blockers can slow the progression of kidney disease.
  • Regular Kidney Health Assessments: If you're at risk for kidney disease, get your kidneys checked every two years, or annually if you have diabetes or high blood pressure. This includes blood and urine tests, and blood pressure measurements.
  • Treat Urinary Tract Infections Promptly: UTIs can impact kidney health, so it's important to address them quickly.
  • Manage Cholesterol: Maintain healthy cholesterol levels through diet and medication if necessary.
  • Healthy Lifestyle Choices: Drink plenty of water, eat a balanced diet low in sugar, fat, and salt, and high in fiber. Also, avoid smoking, limit alcohol intake, maintain a healthy weight, and exercise regularly.

Remember, reduced kidney function can be part of aging but may also indicate kidney damage, requiring a consultation with a general practitioner. [71]

The Promising Role of Supplements in Kidney Disease Management

Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin are emerging as potential treatments for kidney diseases. They repair kidney damage and enhance function by boosting NAD+ levels and activating longevity enzymes.

NMN protects against diabetic kidney damage and may prevent scarring and aging in kidneys. Resveratrol helps in reducing kidney inflammation and oxidative stress, improving overall kidney function. Quercetin, with its antioxidant and anti-inflammatory properties, supports kidney health and reduces the risk of chronic kidney diseases. These benefits, primarily observed in animal studies, highlight the need for more research to confirm their effectiveness in humans.

For a deeper understanding and more comprehensive insights, check out NMN, Resveratrol, and Quercetin. [72,73,74,75,76]

Chronic Obstructive Pulmonary Disease (COPD)

chronic obstructive pulmonary disease

COPD is a common respiratory condition among older adults, often caused by long-term exposure to lung irritants like cigarette smoke. It's characterized by difficulty breathing, cough, and wheezing. COPD is particularly prevalent in those over 65, with studies suggesting that 11% to 18% of this age group may be affected, though mild cases often go undiagnosed.

COPD is also a significant reason for hospitalizations among seniors, accounting for around 20% of such admissions in the U.S. for individuals above 65. This highlights the need for early detection and effective management to slow its progression and improve the quality of life in the elderly. [77]

Key Risk Factors for Chronic Obstructive Pulmonary Disease

COPD, a progressive lung disease, is influenced by various risk factors. Key risk factors include:

  • Tobacco Smoke Exposure: Long-term cigarette smoking, including exposure to secondhand smoke.
  • Asthma: Increased risk for individuals with asthma, especially smokers.
  • Occupational Hazards: Exposure to dust, chemical fumes, and vapors at work.
  • Burning Fuel Fumes: Inhaling fumes from burning fuel in poorly ventilated areas, common in developing countries.
  • Genetics: Alpha-1-antitrypsin deficiency and other genetic factors affecting susceptibility.

Addressing these factors is crucial for COPD prevention and management. This involves lifestyle changes and safety measures in susceptible individuals. [78]

COPD Symptoms in Seniors and Their Impact on Health

COPD in seniors often leads to noticeable health challenges. Early symptoms like shortness of breath during routine activities are commonly overlooked. Recognizing and managing these early signs can significantly improve COPD management. Key symptoms include:

  • Shortness of breath during daily tasks
  • Persistent coughing
  • Rapid fatigue
  • Mucus production
  • Chest tightness or wheezing
  • Decreased appetite

Symptom exacerbations, such as increased breathing difficulties, can occur intermittently, often triggered by external factors like infections or air pollution. These episodes require immediate medical attention, and treatment typically involves medication. In severe cases, hospitalization may be needed. [79,80,81]

Causes and Effects on Lungs in COPD

COPD is primarily caused by tobacco smoking in developed countries, while in developing regions, it often results from exposure to fumes in poorly ventilated homes. Not all chronic smokers develop COPD, but many experience reduced lung function, and some might be misdiagnosed with COPD until further evaluation.

The lungs, consisting of the windpipe, bronchi, and smaller tubes called bronchioles, end in air sacs (alveoli) where oxygen is absorbed and carbon dioxide is exhaled. COPD affects this system by diminishing the natural elasticity of the bronchial tubes and air sacs, leading to over-expansion and trapping air during exhalation. [82,83,84]

Managing COPD in the Elderly

Chronic Obstructive Pulmonary Disease (COPD) is a progressive condition that worsens over time, especially if left untreated. While it cannot be fully cured, effective management can slow its progression and improve quality of life in the elderly. This involves a combination of medication, lifestyle changes, oxygen therapy, and pulmonary rehabilitation.

  • Medication: Treatment often includes inhalers to prevent or manage symptoms and steroids to reduce lung inflammation. Antibiotics may be prescribed for lung infections. For severe cases, hospitalization and intravenous medication might be necessary.
  • Lifestyle Adjustments: Key lifestyle changes include quitting smoking, staying physically active, maintaining hydration, eating a healthy diet, avoiding exposure to poor air quality, and keeping up with vaccinations. Regular healthcare visits and monitoring for any symptom changes are also crucial.
  • Oxygen Therapy: For patients with lowered oxygen levels, supplemental oxygen through masks or nasal cannulas may be prescribed. This can vary from occasional to continuous use, depending on the patient's condition, and significantly enhances daily living and activity levels.
  • Pulmonary Rehabilitation: This comprehensive approach is recommended for all COPD stages. It includes exercise training, educational resources, and behavioral coaching, aiming to improve both physical and mental health.

Adherence to these strategies, especially the cessation of smoking and managing other health issues, is vital for slowing COPD's advancement and maintaining activity levels in the elderly. [85]

Lung Health and Natural Supplements: Exploring Potential Benefits

Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin are being explored for their potential in improving lung health, particularly in conditions like asthma and COPD.

Research suggests NMN may protect lungs from pollution, reduce age-related damage, mitigate harm from smoking and dust inhalation, and help heal lung damage from infections like sepsis and COVID-19 in older adults. Resveratrol has shown potential in reducing lung inflammation and oxidative stress, thus supporting respiratory function. Quercetin, with its anti-inflammatory and antioxidant effects, aids in managing lung conditions and improving overall lung health. Further studies are necessary to validate these benefits in human lung health.

While their role in lung health is promising, further research is necessary. Our full guide provides more comprehensive details. [86,87,88,89,90,91]

Dementia

Dementia

Dementia, primarily seen in the elderly, impairs memory, thinking, and decision-making. While it commonly manifests as Alzheimer's disease, it's not a guaranteed part of aging.

In normal aging, minor memory issues like misplacing items or forgetting names may occur, but these don't signify dementia. Core cognitive abilities usually remain intact.

The prevalence of dementia is rising, with around 5 million affected individuals in the U.S. in 2014, expected to increase to 14 million by 2060. This trend underscores the importance of understanding and addressing dementia. [92]

Signs and Symptoms of Dementia

Dementia presents with various symptoms that differ among individuals. Key indicators to be aware of include:

  • Memory Issues: Difficulty retaining new information and recalling past events.
  • Communication Difficulties: Problems with speech or finding the right words.
  • Impaired Judgment: Challenges in decision-making and problem-solving.
  • Visual Perception Changes: Difficulties in visual understanding, unrelated to typical age-related vision changes.
  • Cognitive Decline: Decreased ability in concentration and logical thinking.

Additionally, some common and noticeable signs of dementia are:

  • Disorientation: Getting lost in familiar places.
  • Language Struggles: Using incorrect or unusual terms for familiar objects.
  • Forgetfulness: Failing to remember the names of close friends or family members.
  • Loss of Memories: Inability to recall long-standing personal memories.
  • Dependency in Daily Tasks: Increasing reliance on others for routine activities.

If these symptoms are observed, consulting a healthcare professional for proper diagnosis and to discuss potential treatment options is crucial. [93]

Risk Factors Contributing to Dementia

Understanding dementia risk is key to prevention and early intervention. Key risk factors include:

  • Age: Mostly affects those over 65.
  • Family History: Greater risk with a family history of dementia.
  • Race/Ethnicity: Higher risk in older African Americans and Hispanics.
  • Cardiovascular Health: Conditions like high blood pressure and smoking increase risk.
  • Traumatic Brain Injuries: Repeated head injuries raise the risk.

These factors, along with lifestyle and environmental influences, are crucial in assessing dementia risk. Identifying these risks can help in formulating effective preventive measures. [94]

Diagnosing Dementia

Dementia diagnosis involves:

  • Evaluating cognitive functions, including memory and problem-solving skills.
  • Conducting physical examinations to rule out other conditions.
  • Performing blood tests to identify underlying health issues.
  • Utilizing brain scans, such as CT or MRI, to detect changes or abnormalities in the brain.

It's important to note that an early and accurate diagnosis can significantly improve the quality of life for individuals with dementia and their caregivers. [95]

Common Types of Dementia

  • Alzheimer’s Disease: Most common, characterized by memory loss and later, physical and personality changes. Family history increases risk.
  • Vascular Dementia: Caused by strokes or reduced brain blood flow. Symptoms vary with brain areas affected; sudden worsening is common.
  • Lewy Body Dementia: Includes memory loss, movement issues, altered alertness, and possibly visual hallucinations.
  • Fronto-Temporal Dementia: Affects personality and behavior with symptoms like inappropriate actions and language difficulties.
  • Mixed Dementia: Often in those over 80, involves multiple dementia types, like Alzheimer’s and vascular dementia, leading to overlapping symptoms.
  • Reversible Causes: Some dementia-like symptoms may be due to reversible factors like medication side effects or vitamin deficiencies.

A proper understanding of these dementia types is essential for correct diagnosis and individualized treatment. [96,97,98]

Treatment Options for Dementia

Treatment for dementia varies depending on its cause. For types like Alzheimer's disease, where there's no cure, the focus is on managing symptoms and protecting brain health through medications and ongoing research. A healthy lifestyle with regular exercise, a balanced diet, and social activities can also help lower the risk of dementia.

Addressing Suspected Dementia

  • Initiate a Conversation: Gently discuss changes and the importance of seeing a healthcare professional.
  • Seek Medical Evaluation: Choose a trusted and comfortable healthcare provider for your loved one.
  • Organize a Family Meeting: Plan and gather important documents like Health Care Directive and Power of Attorney.

Remember to maintain empathy and patience throughout your loved one's dementia journey. [99,100,101,102,103,104,105]

NMN, Resveratrol, and Quercetin's Role in Combating Alzheimer's Disease

Alzheimer's disease significantly impacts the elderly, necessitating new treatments. Nicotinamide Mononucleotide (NMN), Resveratrol, and Quercetin are gaining attention for their potential in brain health.

Studies show NMN's neuroprotective effects in Alzheimer’s rats, improving cognitive abilities and reducing brain plaques and inflammation. Resveratrol has been shown to reduce amyloid-beta plaque formation and oxidative damage in the brain. Quercetin's antioxidant properties support brain health by reducing inflammation and oxidative stress. Research into these supplements' roles in boosting NAD+ levels, crucial for brain health, showed promising results, including improved memory and reduced brain inflammation. While these findings are encouraging, their effectiveness in human Alzheimer's treatment requires further exploration.

For a detailed examination, refer to our complete guide. [106,107,108]

Conclusion

This guide has provided essential insights into managing common age-related health conditions such as hypertension, diabetes, osteoporosis, and dementia. Key strategies include regular health screenings, lifestyle changes, and staying informed about the latest medical advancements.

A notable development in this field is the HealthspanX's Ultra Pure NMN™, Resveratrol™, and Quercetin™, which show promise in enhancing bone strength, supporting kidney and lung health, and offering potential benefits in dementia research. Emphasizing a balanced diet, exercise, and professional medical advice, this guide underscores the importance of proactive health management to improve the quality of life for older adults.

Citations

  1. Rudnicka E, Napierała P, Podfigurna A, Męczekalski B, Smolarczyk R, Grymowicz M. The World Health Organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6-11. doi:10.1016/j.maturitas.2020.05.018
  2. Mitchell E, Walker R. Global ageing: successes, challenges and opportunities. Br J Hosp Med (Lond). 2020;81(2):1-9. doi:10.12968/hmed.2019.0377
  3. Kanasi E, Ayilavarapu S, Jones J. The aging population: demographics and the biology of aging. Periodontol 2000. 2016;72(1):13-18. doi:10.1111/prd.12126
  4. Lunenfeld B, Stratton P. The clinical consequences of an ageing world and preventive strategies. Best Pract Res Clin Obstet Gynaecol. 2013;27(5):643-659. doi:10.1016/j.bpobgyn.2013.02.005
  5. Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol. 2020;43(2):99-107. doi:10.1002/clc.23303
  6. Chentli F, Azzoug S, Mahgoun S. Diabetes mellitus in elderly. Indian J Endocrinol Metab. 2015;19(6):744-752. doi:10.4103/2230-8210.167553
  7. Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25(4):563-vii. doi:10.1016/j.cger.2009.07.007
  8. Delsmann MM, Schmidt C, Mühlenfeld M, et al. Prevalence of osteoporosis and osteopenia in elderly patients scheduled for total knee arthroplasty. Arch Orthop Trauma Surg. 2022;142(12):3957-3964. doi:10.1007/s00402-021-04297-x
  9. Kelsey JL. Risk factors for osteoporosis and associated fractures. Public Health Rep. 1989;104 Suppl(Suppl):14-20.
  10. Ibrahim NA, Nabil N, Ghaleb S. Pathophysiology of the Risk Factors Associated with Osteoporosis and their Correlation to the T-score Value in Patients with Osteopenia and Osteoporosis in the United Arab Emirates. J Pharm Bioallied Sci. 2019;11(4):364-372. doi:10.4103/jpbs.JPBS_4_19
  11. Lems WF, Raterman HG, van den Bergh JP, et al. Osteopenia: a diagnostic and therapeutic challenge. Curr Osteoporos Rep. 2011;9(3):167-172. doi:10.1007/s11914-011-0062-3
  12. Tu KN, Lie JD, Wan CKV, et al. Osteoporosis: A Review of Treatment Options. P T. 2018;43(2):92-104.
  13. McGreevy C, Williams D. Safety of drugs used in the treatment of osteoporosis. Ther Adv Drug Saf. 2011;2(4):159-172. doi:10.1177/2042098611411012
  14. Chen LR, Ko NY, Chen KH. Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. Int J Mol Sci. 2019;20(9):2213. Published 2019 May 6. doi:10.3390/ijms20092213
  15. ElHawary H, Baradaran A, Abi-Rafeh J, Vorstenbosch J, Xu L, Efanov JI. Bone Healing and Inflammation: Principles of Fracture and Repair. Semin Plast Surg. 2021;35(3):198-203. doi:10.1055/s-0041-1732334
  16. Gorter EA, Reinders CR, Krijnen P, Appelman-Dijkstra NM, Schipper IB. The effect of osteoporosis and its treatment on fracture healing a systematic review of animal and clinical studies. Bone Rep. 2021;15:101117. Published 2021 Aug 16. doi:10.1016/j.bonr.2021.101117
  17. Sheen JR, Mabrouk A, Garla VV. Fracture Healing Overview. [Updated 2023 Apr 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551678/
  18. Tarantino U, Cerocchi I, Scialdoni A, et al. Bone healing and osteoporosis. Aging Clin Exp Res. 2011;23(2 Suppl):62-64.
  19. Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: a review. J Womens Health (Larchmt). 2014;23(7):563-572. doi:10.1089/jwh.2013.4611
  20. Pai MV. Osteoporosis Prevention and Management. J Obstet Gynaecol India. 2017;67(4):237-242. doi:10.1007/s13224-017-0994-3
  21. Benjamin RM. Bone health: preventing osteoporosis. Public Health Rep. 2010;125(3):368-370. doi:10.1177/003335491012500302
  22. Li B, Shi Y, Liu M, Wu F, Hu X, Yu F, Wang C, Ye L. Attenuates of NAD+ impair BMSC osteogenesis and fracture repair through OXPHOS. Stem Cell Res Ther. 2022 Feb 22;13(1):77. doi: 10.1186/s13287-022-02748-9. PMID: 35193674; PMCID: PMC8864833.
  23. Hu M, Xing L, Zhang L, Liu F, Wang S, Xie Y, Wang J, Jiang H, Guo J, Li X, Wang J, Sui L, Li C, Liu D, Liu Z. NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation. Aging Cell. 2022 Jan 15:e13551. doi: 10.1111/acel.13551. Epub ahead of print. PMID: 35032339.
  24. Song J, Li J, Yang F, et al. Nicotinamide mononucleotide promotes osteogenesis and reduces adipogenesis by regulating mesenchymal stromal cells via the SIRT1 pathway in aged bone marrow. Cell Death Dis. 2019;10(5):336. Published 2019 Apr 18. doi:10.1038/s41419-019-1569-2
  25. Huang Y, Dou Y, Yang B, He B, Zhang X, Zhang K, Yang X. Nicotinamide mononucleotide supplementation mitigates osteopenia induced by modeled microgravity in rats. Cell Stress Chaperones. 2023 May 17. doi: 10.1007/s12192-023-01356-7. Epub ahead of print. PMID: 37195399.
  26. Huang RX, Tao J. Nicotinamide mononucleotide attenuates glucocorticoid-induced osteogenic inhibition by regulating the SIRT1/PGC-1α signaling pathway. Mol Med Rep. 2020;22(1):145-154. doi:10.3892/mmr.2020.11116
  27. Haipeng Liang, Jian Gao, Chi Zhang, Chunlin Li, Qi Wang, Jiaojiao Fan, Zizheng Wu, Qiugen Wang. Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasome. Toxicol Appl Pharmacol, 2019; DOI: 10.1016/j.taap.2018.10.006.
  28. Fejer R, Leboeuf-Yde C. Does back and neck pain become more common as you get older? A systematic literature review. Chiropr Man Therap. 2012;20(1):24. Published 2012 Aug 10. doi:10.1186/2045-709X-20-24
  29. Moskovich R. Neck pain in the elderly: common causes and management. Geriatrics. 1988;43(4):.
  30. Hartvigsen J, Frederiksen H, Christensen K. Back and neck pain in seniors-prevalence and impact. Eur Spine J. 2006;15(6):802-806. doi:10.1007/s00586-005-0983-6
  31. Wong AYL, Karppinen J, Samartzis D. Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord. 2017;12:14. Published 2017 Apr 18. doi:10.1186/s13013-017-0121-3
  32. Domenichiello AF, Ramsden CE. The silent epidemic of chronic pain in older adults. Prog Neuropsychopharmacol Biol Psychiatry. 2019;93:284-290. doi:10.1016/j.pnpbp.2019.04.006
  33. Wong AYL, Karppinen J, Samartzis D. Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord. 2017;12:14. Published 2017 Apr 18. doi:10.1186/s13013-017-0121-3
  34. Bishwajit G, Tang S, Yaya S, Feng Z. Participation in physical activity and back pain among an elderly population in South Asia. J Pain Res. 2017;10:905-913. Published 2017 Apr 15. doi:10.2147/JPR.S133013
  35. Corp N, Mansell G, Stynes S, et al. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2021;25(2):275-295. doi:10.1002/ejp.1679
  36. Maiers MJ, Hartvigsen J, Schulz C, Schulz K, Evans RL, Bronfort G. Chiropractic and exercise for seniors with low back pain or neck pain: the design of two randomized clinical trials. BMC Musculoskelet Disord. 2007;8:94. Published 2007 Sep 18. doi:10.1186/1471-2474-8-94
  37. Pacheco-da-Costa S, Soto-Vidal C, Calvo-Fuente V, Yuste-Sánchez MJ, Sánchez-Sánchez B, Asúnsolo-Del-Barco Á. Evaluation of Physical Therapy Interventions for Improving Musculoskeletal Pain and Quality of Life in Older Adults. Int J Environ Res Public Health. 2022;19(12):7038. Published 2022 Jun 8. doi:10.3390/ijerph19127038
  38. Jahre H, Grotle M, Smedbråten K, Dunn KM, Øiestad BE. Risk factors for non-specific neck pain in young adults. A systematic review. BMC Musculoskelet Disord. 2020;21(1):366. Published 2020 Jun 9. doi:10.1186/s12891-020-03379-y
  39. Misailidou V, Malliou P, Beneka A, Karagiannidis A, Godolias G. Assessment of patients with neck pain: a review of definitions, selection criteria, and measurement tools. J Chiropr Med. 2010;9(2):49-59. doi:10.1016/j.jcm.2010.03.002
  40. Masaki Igarashi, Masaomi Miura, Yoshiko Nakagawa-Nagahama et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle motility in healthy old men, 09 June 2021. DOI: 10.21203/rs.3.rs-455083/v1
  41. Samuel Lundt, Nannan Zhang, Xiaowan Wang, Luis Polo-Parada, Shinghua Ding. The effect of NAMPT deletion in projection neurons on the function and structure of neuromuscular junction (NMJ) in mice.  Sci Rep, 2020; DOI: 10.1038/s41598-019-57085-4.
  42. Gautam M, Gunay A, Chandel NS, Ozdinler PH. Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy. Sci Rep. 2022 Mar 11;12(1):4287. doi: 10.1038/s41598-022-08068-5. PMID: 35277554.
  43. Ito N, Takatsu A, Ito H, Koike Y, Yoshioka K, Kamei Y, Imai SI. Slc12a8 in the lateral hypothalamus maintains energy metabolism and skeletal muscle functions during aging. Cell Rep. 2022 Jul 26;40(4):111131. doi: 10.1016/j.celrep.2022.111131. PMID: 35905718.
  44. Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021 Jul 8;18(1):54. doi: 10.1186/s12970-021-00442-4. PMID: 34238308; PMCID: PMC8265078.
  45. Stahl A. The Diagnosis and Treatment of Age-Related Macular Degeneration. Dtsch Arztebl Int. 2020;117(29-30):513-520. doi:10.3238/arztebl.2020.0513
  46. org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. Age-related macular degeneration (AMD): Overview. 2006 May 22 [Updated 2018 May 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK315804/
  47. Keenan TDL, Cukras CA, Chew EY. Age-Related Macular Degeneration: Epidemiology and Clinical Aspects. Adv Exp Med Biol. 2021;1256:1-31. doi:10.1007/978-3-030-66014-7_1
  48. Ruia S, Kaufman EJ. Macular Degeneration. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560778/
  49. Armstrong RA, Mousavi M. Overview of Risk Factors for Age-Related Macular Degeneration (AMD). J Stem Cells. 2015;10(3):171-191.
  50. Age-related macular degeneration: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2018 Jan. (NICE Guideline, No. 82.) 6, Risk factors. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536467/
  51. Age-related macular degeneration: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2018 Jan. (NICE Guideline, No. 82.) 7, Diagnosis. Available from: https://www.ncbi.nlm.nih.gov/books/NBK536479/
  52. Mathenge W. Age-related macular degeneration. Community Eye Health. 2014;27(87):49-50.
  53. Moutray T, Chakravarthy U. Age-related macular degeneration: current treatment and future options. Ther Adv Chronic Dis. 2011;2(5):325-331. doi:10.1177/2040622311415895
  54. Ebeling MC, Polanco JR, Qu J, Tu C, Montezuma SR, Ferrington DA. Improving retinal mitochondrial function as a treatment for age-related macular degeneration [published online ahead of print, 2020 May 18]. Redox Biol. 2020;101552. doi:10.1016/j.redox.2020.101552
  55. Qian L, Wei W. Identified risk factors for dry eye syndrome: A systematic review and meta-analysis. PLoS One. 2022;17(8):e0271267. Published 2022 Aug 19. doi:10.1371/journal.pone.0271267
  56. Lin H, Yiu SC. Dry eye disease: A review of diagnostic approaches and treatments. Saudi J Ophthalmol. 2014;28(3):173-181. doi:10.1016/j.sjopt.2014.06.002
  57. Findlay Q, Reid K. Dry eye disease: when to treat and when to refer. Aust Prescr. 2018;41(5):160-163. doi:10.18773/austprescr.2018.048
  58. Huang R, Su C, Fang L, Lu J, Chen J, Ding Y. Dry eye syndrome: comprehensive etiologies and recent clinical trials. Int Ophthalmol. 2022;42(10):3253-3272. doi:10.1007/s10792-022-02320-7
  59. Guo OD LW, Akpek E. The negative effects of dry eye disease on quality of life and visual function. Turk J Med Sci. 2020;50(SI-2):1611-1615. Published 2020 Nov 3. doi:10.3906/sag-2002-143
  60. Yeo S, Tong L. Coping with dry eyes: a qualitative approach. BMC Ophthalmol. 2018;18(1):8. Published 2018 Jan 16. doi:10.1186/s12886-018-0671-z
  61. Meng YF, Pu Q, Dai SY, Ma Q, Li X, Zhu W. Nicotinamide Mononucleotide Alleviates Hyperosmolarity-Induced IL-17a Secretion and Macrophage Activation in Corneal Epithelial Cells/Macrophage Co-Culture System. J Inflamm Res. 2021 Feb 22;14:479-493. doi: 10.2147/JIR.S292764. PMID: 33658825; PMCID: PMC7917392.
  62. Kitai Y, Nangaku M, Yanagita M. Aging-Related Kidney Diseases. Contrib Nephrol. 2021;199:266-273. doi:10.1159/000517708
  63. Żebrowski P, Kulicki P. Problemy nefrologiczne zwiazane z wiekiem [Age-related kidney problems]. Wiad Lek. 2015;68(4 Pt 2):638-641.
  64. Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA. 2019;322(13):1294-1304. doi:10.1001/jama.2019.14745
  65. Mallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond). 2014;11(5):525-535. doi:10.2217/cpr.14.46
  66. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010;17(4):302-307. doi:10.1053/j.ackd.2010.05.002
  67. Chou YH, Chen YM. Aging and Renal Disease: Old Questions for New Challenges. Aging Dis. 2021;12(2):515-528. Published 2021 Apr 1. doi:10.14336/AD.2020.0703
  68. Ortiz A, Mattace-Raso F, Soler MJ, Fouque D. Ageing meets kidney disease. Nephrol Dial Transplant. 2023;38(3):523-526. doi:10.1093/ndt/gfac199
  69. Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 2013;3(4):368-371. doi:10.1038/kisup.2013.79
  70. Chang HJ, Lin KR, Chang JL, Lin MT. Risk Factors for Chronic Kidney Disease in Older Adults with Hyperlipidemia and/or Cardiovascular Diseases in Taipei City, Taiwan: A Community-Based Cross-Sectional Analysis. Int J Environ Res Public Health. 2020;17(23):8763. Published 2020 Nov 25. doi:10.3390/ijerph17238763
  71. Merchant RA, Vathsala A. Healthy aging and chronic kidney disease. Kidney Res Clin Pract. 2022;41(6):644-656. doi:10.23876/j.krcp.22.112
  72. Hasegawa K, Sakamaki Y, Tamaki M, Wakino S. Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2. Sci Rep. 2022 Aug 12;12(1):13712. doi: 10.1038/s41598-022-18147-2. PMID: 35962139; PMCID: PMC9374671.
  73. Yasuda I, Hasegawa K, Sakamaki Y, Muraoka H, Kawaguchi T, Kusahana E, Ono T, Kanda T, Tokuyama H, Wakino S, Itoh H. Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy. J Am Soc Nephrol. 2021 Jun 1;32(6):1355-1370. doi: 10.1681/ASN.2020081188.
  74. Jia Y, Kang X, Tan L, Ren Y, Qu L, Tang J, Liu G, Wang S, Xiong Z and Yang L (2021) Nicotinamide Mononucleotide Attenuates Renal Interstitial Fibrosis After AKI by Suppressing Tubular DNA Damage and Senescence. Front. Physiol. 12:649547. doi: 10.3389/fphys.2021.649547
  75. Li P, Liu Y, Qin X, Chen K, Wang R, Yuan L, Chen X, Hao C, Huang X. SIRT1 attenuates renal fibrosis by repressing HIF-2α. Cell Death Discov. 2021 Mar 23;7(1):59. doi: 10.1038/s41420-021-00443-x. PMID: 33758176.
  76. Yi M, Ma Y, Zhu S, Luo C, Chen Y, Wang Q, Deng H. Comparative proteomic analysis identifies biomarkers for renal aging. Aging (Albany NY). 2020 Nov 6;12(21):21890-21903. doi: 10.18632/aging.104007. Epub 2020 Nov 6. PMID: 33159023; PMCID: PMC7695359.
  77. Devine JF. Chronic obstructive pulmonary disease: an overview. Am Health Drug Benefits. 2008;1(7):34-42.
  78. Yan X, Xu L, Shi B, Wang H, Xu X, Xu G. Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study. J Thorac Dis. 2020;12(10):5347-5356. doi:10.21037/jtd-20-1616
  79. Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA. 2012;308(12):1254-1263. doi:10.1001/jama.2012.12422
  80. Cortopassi F, Gurung P, Pinto-Plata V. Chronic Obstructive Pulmonary Disease in Elderly Patients. Clin Geriatr Med. 2017;33(4):539-552. doi:10.1016/j.cger.2017.06.006
  81. Gooneratne NS, Patel NP, Corcoran A. Chronic obstructive pulmonary disease diagnosis and management in older adults. J Am Geriatr Soc. 2010;58(6):1153-1162. doi:10.1111/j.1532-5415.2010.02875.x
  82. MacNee W. Pathology, pathogenesis, and pathophysiology. BMJ. 2006;332(7551):1202-1204.
  83. Shrikrishna D, Hopkinson NS. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin Med (Lond). 2012;12(1):71-74. doi:10.7861/clinmedicine.12-1-71
  84. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220. Published 2010 Mar 16. doi:10.1371/journal.pmed.1000220
  85. Taffet GE, Donohue JF, Altman PR. Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging. 2014;9:23-30. doi:10.2147/CIA.S52999
  86. Zhang R, Chen S, Wang Z, Ye L, Jiang Y, Li M, Jiang X, Peng H, Guo Z, Chen L, Zhang R, Niu Y, Aschner M, Li D, Chen W. Assessing the Effects of Nicotinamide Mononucleotide Supplementation on Pulmonary Inflammation in Male Mice Subchronically Exposed to Ambient Particulate Matter. Environ Health Perspect. 2023 Jul;131(7):77006. doi: 10.1289/EHP12259. Epub 2023 Jul 17. PMID: 37458712; PMCID: PMC10351503.
  87. Fang T, Yang J, Liu L, Xiao H, Wei X. Nicotinamide mononucleotide ameliorates senescence in alveolar epithelial cells. MedComm (2020). 2021;2(2):279-287. Published 2021 May 27. doi:10.1002/mco2.62
  88. Zhang Y, Huang W, Zheng Z, Wang W, Yuan Y, Hong Q, Lin J, Li X, Meng Y. Cigarette smoke-inactivated SIRT1 promotes autophagy-dependent senescence of alveolar epithelial type 2 cells to induce pulmonary fibrosis. Free Radic Biol Med. 2021 Feb 17:S0891-5849(21)00093-9. doi: 10.1016/j.freeradbiomed.2021.02.013. Epub ahead of print. PMID: 33609723.
  89. Wang L, et al. Nicotinamide Mononucleotide Ameliorates Silica-Induced Lung Injury through the Nrf2-Regulated Glutathione Metabolism Pathway in Mice. Nutrients. 2023; 15(1):143. https://doi.org/10.3390/nu15010143
  90. Tian Y, et al. Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects. J Surg Res. 2022 Nov 5;283:9-18. doi: 10.1016/j.jss.2022.09.030.
  91. Jin R, et al. DNA damage contributes to age-associated differences in SARS-CoV-2 infection. Aging Cell. 2022 Oct 18:e13729. doi: 10.1111/acel.13729.
  92. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1-2):125-132. doi:10.1159/000109998
  93. Sandilyan MB, Dening T. Signs and symptoms of dementia. Nurs Stand. 2015;29(41):42-51. doi:10.7748/ns.29.41.42.e9440
  94. Peters R, Booth A, Rockwood K, Peters J, D'Este C, Anstey KJ. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e022846. Published 2019 Jan 25. doi:10.1136/bmjopen-2018-022846
  95. Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. 2019;322(16):1589-1599. doi:10.1001/jama.2019.4782
  96. Scott KR, Barrett AM. Dementia syndromes: evaluation and treatment. Expert Rev Neurother. 2007;7(4):407-422. doi:10.1586/14737175.7.4.407
  97. Wilbur J. Dementia: Dementia Types. FP Essent. 2023;534:7-11.
  98. Karantzoulis S, Galvin JE. Distinguishing Alzheimer's disease from other major forms of dementia. Expert Rev Neurother. 2011;11(11):1579-1591. doi:10.1586/ern.11.155
  99. Shaji KS, Sivakumar PT, Rao GP, Paul N. Clinical Practice Guidelines for Management of Dementia. Indian J Psychiatry. 2018;60(Suppl 3):S312-S328. doi:10.4103/0019-5545.224472
  100. Wehrmann H, Michalowsky B, Lepper S, Mohr W, Raedke A, Hoffmann W. Priorities and Preferences of People Living with Dementia or Cognitive Impairment - A Systematic Review. Patient Prefer Adherence. 2021;15:2793-2807. Published 2021 Dec 14. doi:10.2147/PPA.S333923
  101. Caramelli P, Marinho V, Laks J, et al. Treatment of dementia: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Dement Neuropsychol. 2022;16(3 Suppl 1):88-100. Published 2022 Nov 28. doi:10.1590/1980-5764-DN-2022-S106PT
  102. Perneczky R. Dementia treatment versus prevention. Dialogues Clin Neurosci. 2019;21(1):43-51. doi:10.31887/DCNS.2019.21.1/rperneczky
  103. Ringman JM, Cummings JL. Current and emerging pharmacological treatment options for dementia. Behav Neurol. 2006;17(1):5-16. doi:10.1155/2006/315386
  104. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission [published correction appears in Lancet. 2023 Sep 30;402(10408):1132]. Lancet. 2020;396(10248):413-446. doi:10.1016/S0140-6736(20)30367-6
  105. Andrade C, Radhakrishnan R. The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments. Indian J Psychiatry. 2009;51(1):12-25. doi:10.4103/0019-5545.44900
  106. Xiaonan Wang, Wuejun Hu, Yang Yang, Toshihiro Takata, Takashi Sakurai. Nicotinamide mononucleotide protects against ß-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res, 2016; DOI: 10.1016/j.brainres.2016.04.060.
  107. Yao Z, Yang W, Gao Z, Jia P. Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease. Neurosci Lett. 2017;647:133-140. doi:10.1016/j.neulet.2017.03.027
  108. Hu Y, Huang Y, Xing S, Chen C, Shen D, Chen J. Aβ promotes CD38 expression in senescent microglia in Alzheimer’s disease. Biol Res. 2022 Mar 3;55(1):10. doi: 10.1186/s40659-022-00379-1. PMID: 35241173; PMCID: PMC8892694.
Back to Longevity Guides